HealthFDA Cancels Cipla Warehouse License in Pune Over Violations
The Maharashtra FDA has canceled the drug sale and distribution license of Cipla Pharma's warehouse in Wadki, Pune, citing regulatory violations. The action follows irregularities found in packaging, storage, documentation, and drug recall processes related to Reactin Plus tablets, a Schedule H drug. Cipla called the decision disappointing and stated compliance with storage and distribution rules. The FDA issued a revised show-cause notice on September 4, and Cipla responded on September 11, with a personal hearing held on September 21.
Amar Ujala··Pune


